From 15 May to 15 December 1994, 2943 patients suspected of having contact dermatitis (1955 women, 988 men) were patch tested with methyldibromoglutaronitrile 0.3%, 0.1% and 0.05% pet. 119 patients (4.0%; women 4.1%), men 3.8%) proved to be allergic. 71% of the reactions were considered to be relevant. In 2/3 of the patients, causative products were cosmetics, in 1/3 moistened toilet tissues. Testing with methyldibromoglutaronitrile at lower concentrations (0.05% and 0.1%) and with commercial allergens (Euxyl® K 400 and methyldibromoglutaronitrile, both containing methyldibromoglutaronitrile 0.1 % >), resulted in a number of false-negative reactions. All preserv atives in the European standard series had lower scores than the 4% positive reactions to methyldi bromoglutaronitrile (formaldehyde 2.0%), MCI/MI (Kathon® CG) 3.2%, parabens 1.0%o, quaternium-15 1.3%). It is concluded that methyldibromoglutaronitrile (present in the commercial pre servative Euxyl® K 400) is an important contact allergen in the Netherlands in cosmetics and moistened toilet tissues. It should be added to cosmetics series and to proctological series. The optimal test concentration is unknow, but may be 0.3% pet. The concentration o f 0.1% methyldi bromoglutaronitrile in the currently available commercial allergens appears to be too low, resulting in a number of false-negative reactions.
In 1991, the Dutch Contact Dermatitis group found a 0.5% frequency of positive reactions to methyldibromoglutaronitrile (1,2-dibromo-2,4-dicyanobutane) in patients suspected of having con tact dermatitis ( 
1). At that time, it was decided to

Materials and Methods
May to 15 December 1994, methyldibroanitrile was added to the European stan ds and tested in all oatients susoected of ment repeat the study after some years, to monitor its having contact dermatitis by the participating possible emergence as an important contact allermembers of the Dutch Contact Dermatitis Workgen, as methyldibromoglutaronitrile was rapidly group. The allergens were prepared by the Re gaining popularity in the cosmetics industry as a gional Inspectorate for Health Protection, Departof Cosmetics, Enschede (JWW). Concenons were 0.05%, 0.1%) and 0.3% w/w pet.; soy lin was added to obtain homogeneous disper->. Therefore, soy lecithin 5% was also tested in atients. In some hospitals, Euxyl® K 400 0.5% (Chemotechnique, containing 0.1% methyldisubstitute for methyl (chloro) isothiazolinone (Ka thon® CG). The latter preservative was, in many European countries, one of the most common allergens (2).
The repeat study, performed in 1994, aimed at determining the current frequency of contact al lergy to methyldibromoglutaronitrile, identifying bromoglutaronitrile) and/or the products that cause dermatitis and exploring the influence of test concentrations on the patch test results. nitrile 0.1% pet. (Trolab) were also tested. The following data were recorded for all patients tested gen in Euxyl® K 400 is virtually always methyldi-0.5% methyldibromoglutaronitrile, does not induce bromoglutaronitrile. The causative products are irritant reactions or sensitization. Therefore, the cosmetics and, notably in the Netherlands, moistenoptimal test concentration may be 0.3-0.5%. ed toilet tissues (1,9) .
Addition of a rarely sensitizing emulsifier, such as In this 1994 study, we found a prevalence of soy lecithin, is advisable for facilitating homogenecontact allergy to methyldibromoglutaronitrile of ous dispersion. Possibly, as sorbitan sesquioleate 4% in a multicentre investigation of 2943 patients does for the fragrance mix (12), such an addition suspected of halving contact dermatitis. Women may enhance the sensitivity of the test system. (4.1%) and men (3.8%) were equally affected, the allergenic products being mainly cosmetics in women and moistened toilet tissues in men.
In 4 years, the prevalence of allergy to methyldibromoglutaronitrile in the Netherlands has in creased from 0.5%) to 4.0%. There are 2 import ant determining factors. 4 years ago, we tested methyldibromoglutaronitrile at 0.05% pet. Our present results clearly show that this % is too low: only 85 of 119 allergic patients (71%) reacted to it. Thus, the actual prevalence in 1991 may have been underestimated. Secondly, the market pene tration of Euxyl® K 400 has rapidly increased. In 1990,13%) of cosmetic products sold in the Netherlands contained the preservative (1). Cur rently, an estimated 25-35% of cosmetic products are preserved with Euxyl® K 400, among which are some of the best selling brands in the main product categories. In addition, in 1994, methyl dibromoglutaronitrile was found to be present in 15 of 24 (63%) brands and types of moist toilet paper (11) .
From this study, we conclude that methyldibro moglutaronitrile is an important contact allergen in the Netherlands, from its presence in cosmetics and moistened toilet tissues. Its current rate of sensitization exceeds that of all preservatives in the European standard series, including (in 9 o f the 11 hospitals ) methyl (chloro) isothiazolinone (Kathon® CG). Therefore, it should be added to cos metics series and to protological series. In coun tries where, as in the Netherlands, contact allergy to methyldibromoglutaronitrile is frequent, the allergen should be added to the European standard series.
The 2nd conclusion concerns the test concen-th of 0.1% and for gens methyldibromoglutaronitrile 0.1%) and Eux yl® K 400 0.5% (containing 0.1% methyldibromog lutaronitrile), is likely to result in false-negatives. The data provided by Tosti et al. (6) 
